Hair Loss in Women

Hair loss in women is common, often under-discussed, and rarely fits the picture most people associate with balding. Where men frequently lose hair in a recognizable temple-and-crown pattern, women more often experience a gradual decline in density across the top of the scalp, a slowly widening part, or a sudden burst of shedding triggered by a hormonal or medical event. Understanding which pattern is happening, and why, is the foundation of any sensible treatment plan.

This pillar page is a starting point for that understanding. It introduces how women's hair loss tends to present, the categories of trigger that physicians evaluate, and the more focused articles in this cluster that go deeper into specific situations.

How women's hair loss differs from men's

In men, androgenetic alopecia typically follows the Norwood pattern, with recession at the temples and thinning at the vertex while a strip of denser hair remains around the back and sides. Most men with pattern loss eventually develop a visible bald area on top of the scalp.

Women with pattern hair loss usually do not follow this trajectory. The hairline at the front is most often preserved, and the temples are not the first place to thin. Instead, density declines diffusely across the central scalp. The first sign is often a part that looks wider than it used to, or a ponytail that feels noticeably thinner than it did a year or two ago. The crown may thin gradually, but the dramatic vertex baldness seen in men is uncommon.

This pattern has a name: female pattern hair loss. It is graded on the Ludwig scale (I, II, and III) rather than the Norwood scale, and the difference matters because it affects what the loss looks like, when patients first notice it, and how treatment is approached. The detailed walk-through is on the female pattern hair loss page.

The biology underneath is similar to what happens in men. Androgens, particularly DHT, interact with susceptible hair follicles and drive a process called follicle miniaturization, in which each successive hair from a given follicle grows a little finer and a little shorter than the one before. Women produce androgens at lower levels than men, but the receptors in scalp follicles can still respond, and genetic susceptibility plays a major role in whether that response shows up as hair loss.

Categories of trigger to consider

When a woman notices hair thinning, physicians generally think in four broad categories. The history, the timing, and the pattern of loss point toward which one is most relevant.

Genetic and androgen-mediated

This is female pattern hair loss, the female equivalent of androgenetic alopecia. It tends to be progressive, slowly worsening over years, and often runs in families. The pattern is the diffuse central thinning described above. Treatment focuses on slowing miniaturization with topical or oral minoxidil and, in selected cases, an oral anti-androgen such as spironolactone. The full discussion is on the treatment options page.

Hormonal life events

Pregnancy, the postpartum period, and menopause all involve major shifts in estrogen and androgen levels, and the hair growth cycle is sensitive to those shifts.

• Postpartum shedding is the classic example: estrogen falls sharply after delivery, a large fraction of follicles enter the resting telogen phase together, and a synchronized shed becomes visible a few months later. The postpartum hair loss page covers timeline and what is normal versus what warrants evaluation.
• Perimenopause and menopause bring a slower decline in estrogen and a relative increase in the influence of androgens. Women who carry genetic susceptibility to pattern hair loss often see it become noticeable during this transition. See menopausal hair loss.

Endocrine and medical

Several conditions can cause or accelerate hair loss independent of pattern loss, and some can drive a pattern that closely mimics female pattern hair loss.

• Polycystic ovary syndrome (PCOS) is associated with elevated androgen activity, which can produce scalp thinning along with excess hair growth on the face or body. The mechanism and treatment options are covered on the PCOS and hair loss page.
• Thyroid disorders (both hypothyroidism and hyperthyroidism), iron deficiency, and vitamin D deficiency are common contributors that respond to treatment of the underlying cause.
• Autoimmune conditions such as alopecia areata produce a different pattern (patchy, well-defined areas) and require dermatologic evaluation.

Lifestyle and stress

Acute physical or psychological stress, rapid weight loss, restrictive dieting, and certain medications can trigger telogen effluvium, a diffuse shed that usually peaks two to three months after the trigger and recovers over the following six to twelve months. Chronic versions can persist longer. See diffuse hair thinning in women for the differential and how physicians work it up.

Why diagnosis comes before treatment

A medication that helps female pattern hair loss is not the right answer for hair loss caused by an iron deficiency or an undertreated thyroid. The opposite is also true: correcting iron stores will not address pattern loss in a woman whose ferritin is normal. This is why the standard evaluation in women includes a focused history, a scalp examination, and laboratory testing for the conditions that commonly contribute, before any treatment plan is finalized.

A useful rule of thumb is that a sudden, dramatic shed (handfuls in the shower, hair coming out by the roots) is more likely to be telogen effluvium or a medical trigger, while a gradual decline in density over years is more likely to be pattern loss. The two can also overlap, particularly when a hormonal event unmasks underlying genetic susceptibility.

What treatment may involve

For women with female pattern hair loss, the medications with the strongest evidence base are minoxidil (topical and, in some clinical settings, low-dose oral) and spironolactone, an anti-androgen. Finasteride and dutasteride are used cautiously and selectively in women, and generally not in those who could become pregnant, because of risks to fetal development. The treatment options page goes through the evidence and trade-offs in detail.

For telogen effluvium, the central principle is that hair almost always recovers once the trigger is identified and addressed. Treatment in that situation is more about ruling out persistent contributors and waiting out the cycle than starting a long-term medication.

For PCOS-driven loss, treatment generally combines an anti-androgen with topical minoxidil and addresses the underlying metabolic picture when relevant. For postpartum shedding within the first year after delivery, watchful waiting is usually appropriate, with evaluation if shedding persists past twelve months or appears to unmask a different pattern.

Realistic timelines matter. Hair grows slowly. Even effective treatments take four to six months to begin showing visible change, and the full benefit may take twelve months or longer. The how long does hair loss treatment take page has more on what to expect.

Browse this topic

The articles below go deeper into each major scenario covered above:

• Female pattern hair loss: how it differs from male pattern, how it is graded and diagnosed, and the evidence base for treatment.
• Postpartum hair loss: the biology of the shed, the typical timeline, and when to seek evaluation.
• Menopausal hair loss: hormonal shifts in perimenopause and after menopause, and how they affect hair density.
• PCOS and hair loss: the mechanism connecting insulin resistance, androgen elevation, and scalp thinning.
• Hair loss treatment for women: a closer look at minoxidil, spironolactone, and supportive care.
• Diffuse hair thinning in women: causes beyond pattern loss and the typical workup.

Considering medical assessment

If hair loss is bothering you, persisting beyond what feels like a normal shed, or is associated with other symptoms such as fatigue, weight changes, or menstrual irregularity, a medical evaluation is the most useful first step. A physician can take a history, examine the scalp, order targeted laboratory tests, and identify whether a single cause or a combination of factors is driving what you are seeing. From there, treatment can be matched to the underlying picture rather than guessed at.

How Curekey works describes the process for an online medical consultation, including what to expect from intake, evaluation, and any prescribed treatment plan. The broader hair loss overview covers the biology of the hair growth cycle and pattern loss in more general terms.

Hair loss in women is treatable in many cases, but the right plan depends on identifying what is actually causing it. The pages in this cluster are written to help you arrive at that conversation with better questions and clearer expectations.